The natural history of multiple system atrophy: a prospective European cohort study

Gregor K Wenning, Felix Geser, Florian Krismer, Klaus Seppi, Susanne Duerr, Sylvia Boesch, Martin Köllensperger, Georg Goebel, Karl P Pfeiff er, Paolo Barone, Maria Teresa Pellecchia, Niall P Quinn, Vasiliki Koukouni, Clare J Fowler, Anette Schrag, Christopher J Mathias, Nir Giladi, Tanya Gurevich, Erik Dupont, Karen Ostergaard, Christer F Nilsson, Håkan Widner, Wolfgang Oertel, Karla Maria Eggert, Alberto Albanese, Francesca del Sorbo, Eduardo Tolosa, Adriana Cardozo, Günther Deuschl, Helge Hellriegel, Thomas Klockgether, Richard Dodel, Cristina Sampaio, Miguel Coelho, Ruth Djaldetti, Eldad Melamed, Thomas Gasser, Christoph Kamm, Giuseppe Meco, Carlo Colosimo, Olivier Rascol, Wassilios G Meissner, François Tison, Werner Poewe, for The European Multiple System Atrophy Study Group

[1]  E. Tolosa,et al.  Premotor signs and symptoms of multiple system atrophy , 2012, The Lancet Neurology.

[2]  S. Gilman,et al.  Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[3]  Albert C. Ludolph,et al.  Disease Severity and Progression in Progressive Supranuclear Palsy and Multiple System Atrophy: Validation of the NNIPPS – PARKINSON PLUS SCALE , 2011, PloS one.

[4]  W. Oertel,et al.  Health-Related Quality of Life in Multiple System Atrophy and Progressive Supranuclear Palsy , 2011, Neurodegenerative Diseases.

[5]  C. Colosimo.  Nonmotor presentations of multiple system atrophy , 2011, Nature Reviews Neurology.

[6]  M. T. Pellecchia,et al.  Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry , 2010, Movement disorders : official journal of the Movement Disorder Society.

[7]  M. Jahanshahi,et al.  A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy , 2010, Movement disorders : official journal of the Movement Disorder Society.

[8]  Alexander Gerhard,et al.  Minocycline 1‐year therapy in multiple‐system‐atrophy: Effect on clinical symptoms and [11C] (R)‐PK11195 PET (MEMSA‐trial) , 2010, Movement disorders : official journal of the Movement Disorder Society.

[9]  Sid Gilman,et al.  Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. , 2009, Archives of neurology.

[10]  G. Wenning,et al.  Recent developments in multiple system atrophy , 2009, Journal of Neurology.

[11]  Y. Agid,et al.  Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study , 2008, Brain : a journal of neurology.

[12]  P. Kempster,et al.  Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. , 2008, Brain : a journal of neurology.

[13]  W. Poewe,et al.  Rasagiline is neuroprotective in a transgenic model of multiple system atrophy , 2008, Experimental Neurology.

[14]  N. Quinn,et al.  Survival in multiple system atrophy , 2008, Movement disorders : official journal of the Movement Disorder Society.

[15]  J. Jankovic,et al.  Potential outcome measures and trial design issues for multiple system atrophy , 2007, Movement disorders : official journal of the Movement Disorder Society.

[16]  C. Mathias,et al.  Measuring health‐related quality of life in MSA: The MSA‐QoL , 2007, Movement disorders : official journal of the Movement Disorder Society.

[17]  W. Poewe,et al.  Microglial activation mediates neurodegeneration related to oligodendroglial α‐synucleinopathy: Implications for multiple system atrophy , 2007, Movement disorders : official journal of the Movement Disorder Society.

[18]  E. Tolosa,et al.  Safety and tolerability of growth hormone therapy in multiple system atrophy: A double‐blind, placebo‐controlled study , 2007, Movement disorders : official journal of the Movement Disorder Society.

[19]  S. van Buuren.  Multiple imputation of discrete and continuous data by fully conditional specification , 2007, Statistical methods in medical research.

[20]  C. Mathias,et al.  Progression of dysautonomia in multiple system atrophy: a prospective study of self‐perceived impairment , 2007, European journal of neurology.

[21]  M. T. Pellecchia,et al.  Health‐related quality of life in multiple system atrophy , 2006, Movement disorders : official journal of the Movement Disorder Society.

[22]  C. Tranchant,et al.  [Subthalamic stimulation in a patient with multiple system atrophy: a clinicopathological report]. , 2006, Revue neurologique.

[23]  M. T. Pellecchia,et al.  Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG) , 2006, Movement disorders : official journal of the Movement Disorder Society.

[24]  F. Kopper,et al.  The European Multiple System Atrophy-Study Group (EMSA-SG) , 2005, Journal of Neural Transmission.

[25]  Sid Gilman,et al.  Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS) , 2004, Movement disorders : official journal of the Movement Disorder Society.

[26]  J. Zarranz,et al.  Parkinson's disease‐like presentation of multiple system atrophy with poor response to STN stimulation: A clinicopathological case report , 2004, Movement disorders : official journal of the Movement Disorder Society.

[27]  Gordon H Baltuch,et al.  Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report. , 2004, Journal of neurosurgery.

[28]  E. Tolosa,et al.  Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: A clinicopathological case study , 2002, Movement disorders : official journal of the Movement Disorder Society.

[29]  Y. Abe,et al.  Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients. , 2002, Brain : a journal of neurology.

[30]  H U Rehman,et al.  Multiple system atrophy , 2001, Postgraduate medical journal.

[31]  I Litvan,et al.  Progression of Hoehn and Yahr stages in parkinsonian disorders: A clinicopathologic study , 2000, Neurology.

[32]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[33]  W. Poewe,et al.  The natural history of parkinson's disease , 1998, Journal of neurology.

[34]  T Klockgether,et al.  The natural history of degenerative ataxia: a retrospective study in 466 patients. , 1998, Brain : a journal of neurology.

[35]  N. Quinn,et al.  Multiple system atrophy: A review of 203 pathologically proven cases , 1997, Movement disorders : official journal of the Movement Disorder Society.

[36]  J. Dichgans,et al.  Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[37]  N P Quinn,et al.  Clinical features and natural history of multiple system atrophy. An analysis of 100 cases. , 1994, Brain : a journal of neurology.

[38]  M Schulzer,et al.  Clinical observations on the rate of progression of idiopathic parkinsonism. , 1994, Brain : a journal of neurology.

[39]  D. Spencer,et al.  Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. , 1992, The New England journal of medicine.

[40]  N. Quinn,et al.  Multiple system atrophy--the nature of the beast. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[41]  M. Hoehn,et al.  Parkinsonism , 1967, Neurology.

[42]  Klaus Seppi,et al.  Progression of parkinsonism in multiple system atrophy , 2005, Journal of Neurology.

[43]  D. Robinson,et al.  Modelling survival data in medical research, second edition , 2004 .

[44]  A. Koeppen.  Consensus statement on the diagnosis of multiple system atrophy. , 1999, Journal of the neurological sciences.

[45]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[46]  A. Kasuya.  EuroQol--a new facility for the measurement of health-related quality of life. , 1990, Health policy.

[47]  Z. Schwab,et al.  Projection technique for evaluating surgery in Parkinson’s disease , 1969 .